Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The emerging role of regulatory cell-based therapy in autoimmune disease.
Ghobadinezhad F, Ebrahimi N, Mozaffari F, Moradi N, Beiranvand S, Pournazari M, Rezaei-Tazangi F, Khorram R, Afshinpour M, Robino RA, Aref AR, Ferreira LMR. Ghobadinezhad F, et al. Among authors: ebrahimi n. Front Immunol. 2022 Dec 14;13:1075813. doi: 10.3389/fimmu.2022.1075813. eCollection 2022. Front Immunol. 2022. PMID: 36591309 Free PMC article. Review.
Role of the Wnt and GTPase pathways in breast cancer tumorigenesis and treatment.
Ebrahimi N, Kharazmi K, Ghanaatian M, Miraghel SA, Amiri Y, Seyedebrahimi SS, Mobarak H, Yazdani E, Parkhideh S, Hamblin MR, Aref AR. Ebrahimi N, et al. Cytokine Growth Factor Rev. 2022 Oct;67:11-24. doi: 10.1016/j.cytogfr.2022.05.001. Epub 2022 May 5. Cytokine Growth Factor Rev. 2022. PMID: 35934612 Review.
Crosstalk between lncRNAs in the apoptotic pathway and therapeutic targets in cancer.
Ebrahimi N, Parkhideh S, Samizade S, Esfahani AN, Samsami S, Yazdani E, Adelian S, Chaleshtori SR, Shah-Amiri K, Ahmadi A, Aref AR. Ebrahimi N, et al. Cytokine Growth Factor Rev. 2022 Jun;65:61-74. doi: 10.1016/j.cytogfr.2022.04.003. Epub 2022 Apr 20. Cytokine Growth Factor Rev. 2022. PMID: 35597701 Review.
Targeting the metabolism of cancer stem cells by energy disruptor molecules.
Dadgar T, Ebrahimi N, Gholipour AR, Akbari M, Khani L, Ahmadi A, Hamblin MR. Dadgar T, et al. Among authors: ebrahimi n. Crit Rev Oncol Hematol. 2022 Jan;169:103545. doi: 10.1016/j.critrevonc.2021.103545. Epub 2021 Nov 24. Crit Rev Oncol Hematol. 2022. PMID: 34838705 Review.
208 results